Home

samle angre Deqenereret teva sec filings Privilegium Rudyard Kipling Lærd

Stock Forecast Based On a Predictive Algorithm | I Know First |Stock  Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in  Teva Stock
Stock Forecast Based On a Predictive Algorithm | I Know First |Stock Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in Teva Stock

Teva Gains 6.4% on Another Opioid Case Settlement - TipRanks.com
Teva Gains 6.4% on Another Opioid Case Settlement - TipRanks.com

DEF 14A
DEF 14A

Teva won't say whether R&D cuts include layoffs; Cipla inks deal for  Iranian plant; | Fierce Pharma
Teva won't say whether R&D cuts include layoffs; Cipla inks deal for Iranian plant; | Fierce Pharma

Teva Announces Successful Upsize and Pricing of $2,490,000,000 (equivalent)  Sustainability-Linked Senior Notes and the Increase of the Maximum Tender  Amount of its Debt Tender Offer | Business Wire
Teva Announces Successful Upsize and Pricing of $2,490,000,000 (equivalent) Sustainability-Linked Senior Notes and the Increase of the Maximum Tender Amount of its Debt Tender Offer | Business Wire

DEF 14A
DEF 14A

Teva ponies up $420M to settle with investors who said company hid  price-fixing scheme | Fierce Pharma
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma

TEVA PHARMACEUTICAL INDUSTRIES LTD Form 10-Q Quarterly Report Filed  2022-05-03
TEVA PHARMACEUTICAL INDUSTRIES LTD Form 10-Q Quarterly Report Filed 2022-05-03

Teva Investor Relations by Teva Pharmaceuticals USA, Inc.
Teva Investor Relations by Teva Pharmaceuticals USA, Inc.

Teva: New Generic Launches Will Benefit Earnings (NYSE:TEVA) | Seeking Alpha
Teva: New Generic Launches Will Benefit Earnings (NYSE:TEVA) | Seeking Alpha

DEF 14A
DEF 14A

Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug  Development and Chronic Disease Management with
Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with

DEF 14A
DEF 14A

US88163VAE92 Institutional Ownership and Shareholders - Teva Pharmaceutical  Fin Llc Bond
US88163VAE92 Institutional Ownership and Shareholders - Teva Pharmaceutical Fin Llc Bond

Teva Pharmaceutical Industries Limited (TEVA) Company Profile & Overview -  Stock Analysis
Teva Pharmaceutical Industries Limited (TEVA) Company Profile & Overview - Stock Analysis

SEC Subpoena For Teva | The FCPA Blog
SEC Subpoena For Teva | The FCPA Blog

TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical  Industries Ltd. (NYSE) Stock
TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical Industries Ltd. (NYSE) Stock

US88167AAE10 Institutional Ownership and Shareholders - Teva Pharmaceutical  Fin Neth 10/01/2026 3.150 Bond
US88167AAE10 Institutional Ownership and Shareholders - Teva Pharmaceutical Fin Neth 10/01/2026 3.150 Bond

DEF 14A
DEF 14A

DEF 14A
DEF 14A

As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech
As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech

Teva lures Lundbeck chief Schultz with $52M package that makes him among  pharma's top paid | Fierce Pharma
Teva lures Lundbeck chief Schultz with $52M package that makes him among pharma's top paid | Fierce Pharma

Form 10-K
Form 10-K

Teva Pharmaceutical Industries Limited (TEVA) Market Cap (2012-2022) History
Teva Pharmaceutical Industries Limited (TEVA) Market Cap (2012-2022) History

Teva Investor Relations on the App Store
Teva Investor Relations on the App Store